Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
KQ-2003 CAR-T in Relapsed or Refractory Multiple Myeloma
NCT04714827Phase 2Recruiting
- Sponsor
- Shanxi Cancer Hospital
- Start
- Jan 2021
- Primary completion
- Sep 2024
- Modality
- CAR-T Cells
- Countries
- 1
01
Overview
A Phase 2 trial of KQ-2003 in multiple myeloma (MM), sponsored by Shanxi Cancer Hospital. Started Jan 2021; status: recruiting.
02
Drugs
KQ-2003
03
Conditions
multiple myeloma (MM)
Beyond the preview
Go deeper on NCT04714827.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04714827.